-
平臺(tái)編號(hào)：bio-47795
-
國際編號(hào)：ATCC 50143
-
拉丁屬名： richomonas vaginalis Donne
-
規(guī)格：frozen
-
用途：ATCC原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
陰道毛滴蟲
ATCC? Number:50143?
Organism: Trichomonas vaginalis Donne
Designations: CDC 085
Isolation: human, Columbus, OH, 1980
Depositors: M Muller
History: ATCC<<--M Muller<<--J.G. Lossick
Biosafety Level:2
Shipped: frozen
Growth Conditions: ATCCmedium 2154: LYI Entamoeba mediumTemperature: 35.0℃ Duration: axenic; anaerobic Protocol: at pH 6.0
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments: metronidazole-resistant [46485] [58183] Antioxidant defences [21764] phospholipid metabolism [4649]
References: 4647: Lloyd D, Pedersen JZ. Metronidazole radical anion generation in vivo in Trichomonas vaginalis: oxygen quenching is enhanced in a drug-resistant strain. J. Gen. Microbiol. 131: 87-92, 1985. PubMed: 2985740 4649: Beach DH, et al. Phospholipid metabolism of cultured Trichomonas vaginalis and Tritrichomonas foetus. Mol. Biochem. Parasitol. 44: 97-108, 1991. PubMed: 2011157 21764: Ellis JE, et al. Antioxidant defences in the microaerophilic protozoan Trichomonas vaginalis: comparison of metronidazole-resistant and sensitive strains. Microbiology 140: 2489-2494, 1994. PubMed: 7952198 23976: Muller M. Mode of action of metronidazole on anaerobic bacteria and protozoa. Surgery 93: 165-171, 1983. PubMed: 6849201 32939: Vanacova S, et al. Characterization of Trichomonad species and strains by PCR fingerprinting. J. Eukaryot. Microbiol. 44: 545-552, 1997. PubMed: 9435127 46485: Meri T, et al. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations. J. Clin. Microbiol. 38: 763-767, 2000. PubMed: 10655382 58183: Muller M, et al. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex. Transm. Dis. 15: 17-24, 1988. PubMed: 3258675 70353: Bouma MJ, et al. Activity of disulfiram (bis(diethylthiocarbamoyl)disulphide) and ditiocarb (diethyldithiocarbamate) against metronidazole-sensitive and -resistant Trichomonas vaginalis and Tritrichomonas foetus. J. Antimicrob. Chemother. 42: 817-820, 1998. PubMed: 10052908 70372: Adagu IS, et al. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J. Antimicrob. Chemother. 49: 103-111, 2002. PubMed: 11751773
metronidazole-resistant [46485] [58183] Antioxidant defences [21764] phospholipid metabolism [4649]
